Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,319) with videos related to
Page
of 132
Sort By:
COPD
|
December 21, 2006
Systemic inflammation in COPD: is genetic susceptibility a key factor?
Dilyara G Yanbaeva, Mieke A Dentener, Eva C Creutzberg, et al.
COPD
|
December 21, 2006
Safety of sputum induction in moderate-to-severe smoking-related chronic obstructive pulmonary disease
Andrew M Wilson, Richard Leigh, Frederick E Hargreave, et al.
COPD
|
March 17, 2007
Mortality and functional performance in severe emphysema after lung volume reduction or transplant
Michael S Weinstein, Ubaldo J Martin, Aaron D Crookshank, et al.
COPD
|
September 26, 2006
Trends and ethnic differences in COPD hospitalization and mortality in Singapore
Tze Pin Ng, Muhamad Niti, Wan Cheng Tan
COPD
|
September 26, 2006
Comparison of oral and depot intra-muscular steroids in assessing steroid-responsiveness in COPD
Noemi Eiser, Christopher Phillips, Patricia Wooler, et al.
COPD
|
May 29, 2007
Evaluation of small sample cDNA amplification for microdissected airway expression profiling in COPD
John V Gosselink, Shizu Hayashi, Edmond Chau, et al.
COPD
|
May 29, 2007
Insulin resistance and inflammation - A further systemic complication of COPD
C E Bolton, M Evans, A A Ionescu, et al.
COPD
|
May 29, 2007
Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone
Douglas W Mapel, Leila S Nelson, Eva Lydick, et al.
COPD
|
January 24, 2007
Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening
Frederick J de Serres, Ignacio Blanco, Enrique Fernández-Bustillo
COPD
|
January 24, 2007
Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD
Marc Decramer, Gary Ferguson
Page
of 132
Search research articles
Search
Showing results (1011-1020 of 1,319) with videos related to
Sort By:
Page
of 132
COPD
|
December 21, 2006
Systemic inflammation in COPD: is genetic susceptibility a key factor?
Dilyara G Yanbaeva, Mieke A Dentener, Eva C Creutzberg, et al.
COPD
|
December 21, 2006
Safety of sputum induction in moderate-to-severe smoking-related chronic obstructive pulmonary disease
Andrew M Wilson, Richard Leigh, Frederick E Hargreave, et al.
COPD
|
March 17, 2007
Mortality and functional performance in severe emphysema after lung volume reduction or transplant
Michael S Weinstein, Ubaldo J Martin, Aaron D Crookshank, et al.
COPD
|
September 26, 2006
Trends and ethnic differences in COPD hospitalization and mortality in Singapore
Tze Pin Ng, Muhamad Niti, Wan Cheng Tan
COPD
|
September 26, 2006
Comparison of oral and depot intra-muscular steroids in assessing steroid-responsiveness in COPD
Noemi Eiser, Christopher Phillips, Patricia Wooler, et al.
COPD
|
May 29, 2007
Evaluation of small sample cDNA amplification for microdissected airway expression profiling in COPD
John V Gosselink, Shizu Hayashi, Edmond Chau, et al.
COPD
|
May 29, 2007
Insulin resistance and inflammation - A further systemic complication of COPD
C E Bolton, M Evans, A A Ionescu, et al.
COPD
|
May 29, 2007
Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone
Douglas W Mapel, Leila S Nelson, Eva Lydick, et al.
COPD
|
January 24, 2007
Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening
Frederick J de Serres, Ignacio Blanco, Enrique Fernández-Bustillo
COPD
|
January 24, 2007
Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD
Marc Decramer, Gary Ferguson
Page
of 132